Yokohama, Japan

Kenzo Omata

This inventor holds 3 USPTO granted patents. Top assignee: Mitsubishi Chemical Industries Limited. Active years: 1978-1980.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kenzo Omata. Retrieved from https://idiyas.com/inventor/kenzo-omata

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1978-1980

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Kenzo Omata: Innovator in Antibacterial Agents

Introduction

Kenzo Omata is a notable inventor based in Yokohama, Japan. He has made significant contributions to the field of antibacterial agents through his innovative work. With a total of 3 patents, Omata has established himself as a key figure in his area of expertise.

Latest Patents

Omata's latest patents include the development of amino acid derivatives of 6-(2-amino-2-arylacetamido)penicillanic acids. These compounds have been prepared and shown to be useful as antibacterial agents. His work in this area highlights the potential for new treatments in combating bacterial infections.

Career Highlights

Kenzo Omata is currently associated with Mitsubishi Chemical Industries Limited, where he continues to advance his research and development efforts. His career has been marked by a commitment to innovation and the pursuit of effective solutions in the pharmaceutical industry.

Collaborations

Throughout his career, Omata has collaborated with esteemed colleagues such as Yoshiharu Morita and Junichi Ohya. These partnerships have contributed to the success of his projects and the advancement of their shared goals in research.

Conclusion

Kenzo Omata's work in the field of antibacterial agents demonstrates his dedication to innovation and the development of effective medical solutions. His contributions are valuable to the ongoing efforts in combating bacterial infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…